Altimmune, Inc. · NASDAQ:ALT
State Street Corp reported a 5.50% stake in Altimmune, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.50% stake in Altimmune, Inc., 7,145,550 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 7,145,550
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.50% | 7,145,550 |
Source
Related
- Altimmune, Inc.
- State Street Corp
- Altimmune, Inc. shareholders
- Schedule 13G · State Street Corp · Nov 10, 2026
- Form 4 · Menziuso Richard Thomas · Nov 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 16, 2026
- Form 4 · Pisano Wayne · Nov 13, 2026
- Form 4 · Weaver Gregory L · Nov 13, 2026
- Form 4 · Durso Jerome Benedict · Nov 13, 2026